CLX
65
2
APA
30
5
CTAS
36
8
BK
60
2
SPG
45
2
AMGN
42
14
MKC
54
3
NOV
45
2
CMA
42
3
CVX
25
14
MA
60
5
DIS
70
2
PFE
37
4
INTU
54
2
MTB
38
4
BXP
39
5
PDCO
77
3
HAL
40
11
DGX
28
4
O
26
16
CLX
65
2
APA
30
5
CTAS
36
8
BK
60
2
SPG
45
2
AMGN
42
14
MKC
54
3
NOV
45
2
CMA
42
3
CVX
25
14
MA
60
5
DIS
70
2
PFE
37
4
INTU
54
2
MTB
38
4
BXP
39
5
PDCO
77
3
HAL
40
11
DGX
28
4
O
26
16
Financhill
Back

PeptiDream 10K Form

Buy
60

PPTDF
PeptiDream

Last Price:
$17.15
Seasonality Move:
-2.08%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive PPTDF News And Ratings

See the #1 stock for the next 7 days that we like better than PPTDF

PPTDF Financial Statistics

Sales & Book Value

Annual Sales: $204.6M
Cash Flow: $173.8M
Price / Cash Flow: 12.97
Annual Sales: $3.16
Price / Book: 5.43

Profitability

EPS (TTM): 0.84160
Net Income (TTM): $109.2M
Gross Margin: $122.7M
Return on Equity: 34.66%
Return on Assets: 20.65%

PeptiDream Earnings Forecast

Key PeptiDream Financial Ratios

  • The Gross Profit Margin over the past 12 years for PPTDF is 59.97%.
  • The Selling, General & Administrative Expenses for PPTDF have been equal to 25.27% of Gross Profit Margin.
  • The Research & Development expenses have been 10.99% of Revenue.
  • The Interest Expense is 74.21% of Operating Income.
  • The Net Earning history of PPTDF is 10.57% of Total Revenues.
  • Per Share Earnings over the last 12 years have been positive in 7 years.

PeptiDream Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Biotechnology
Sector: Health Care
Current Symbol: PPTDF
Website: peptidream.com

Debt

Debt-to-Equity Ratio: 0.35
Current Ratio: 3.51
Quick Ratio: 3.28

Price-to-Earnings

Trailing P/E Ratio: 102.92
Forward P/E Ratio: 0

PPTDF Technical Analysis vs Fundamental Analysis

Buy
60
PeptiDream (PPTDF) is a Buy

Is PeptiDream a Buy or a Sell?

  • PeptiDream stock is rated a Buy
    The current PeptiDream [PPTDF] share price is $17.15. The Score for PPTDF is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.